Phreesia, Inc.

NYSE PHR

Phreesia, Inc. Revenue for the Trailing 12 Months (TTM) ending October 31, 2024: USD 405.14 M

Phreesia, Inc. Revenue is USD 405.14 M for the Trailing 12 Months (TTM) ending October 31, 2024, a 19.91% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Phreesia, Inc. Revenue for the Trailing 12 Months (TTM) ending October 31, 2023 was USD 337.88 M, a 28.79% change year over year.
  • Phreesia, Inc. Revenue for the Trailing 12 Months (TTM) ending October 31, 2022 was USD 262.34 M, a 33.16% change year over year.
  • Phreesia, Inc. Revenue for the Trailing 12 Months (TTM) ending October 31, 2021 was USD 197.02 M, a 41.05% change year over year.
  • Phreesia, Inc. Revenue for the Trailing 12 Months (TTM) ending October 31, 2020 was USD 139.68 M, a 17.92% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
NYSE: PHR

Phreesia, Inc.

CEO Mr. Chaim Indig
IPO Date July 18, 2019
Location United States
Headquarters 434 Fayetteville Street
Employees 1,438
Sector Technology
Industries
Description

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.

Similar companies

PRVA

Privia Health Group, Inc.

USD 21.00

1.25%

EVH

Evolent Health, Inc.

USD 11.18

-9.77%

NRC

National Research Corporation

USD 16.93

-1.97%

CERT

Certara, Inc.

USD 10.74

-2.10%

DH

Definitive Healthcare Corp.

USD 3.92

-0.25%

HSTM

HealthStream, Inc.

USD 31.47

1.68%

HCAT

Health Catalyst, Inc.

USD 5.90

-9.09%

StockViz Staff

January 15, 2025

Any question? Send us an email